Information
-
Trademark
-
88191008
-
International Classifications
-
Filing Date
November 12, 2018
6 years ago
-
Transaction Date
September 24, 2019
5 years ago
-
Status Date
September 24, 2019
5 years ago
-
Location Date
September 24, 2019
5 years ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
Employee Name
MARTIN, EUGENIA K
-
Attorney Docket Number
1114570
Attorney Name
MARGARET C. MCHUGH
Law Office Assigned Location Code
M50
-
Owners
Mark Drawing Code
4000
Mark Identification
ATGENGLOBAL
Case File Statements
- GS0011: Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
- GS0051: Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
- GS0351: Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
- GS0401: Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
- GS0421: medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
- PM0001: AT GEN GLOBAL
Case File Event Statements
-
9/24/2019 - 5 years ago
8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
9/24/2019 - 5 years ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
2/26/2019 - 5 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/26/2019 - 5 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/26/2019 - 5 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/14/2019 - 5 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/30/2018 - 6 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
11/15/2018 - 6 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP